Scorpius CEO acknowledges agreement with state to build Manhattan facility is no more

By Rose Gruenbacher Scorpius BioManufacturing officials on Thursday told The Mercury the original deal they made with the state to construct a $650-million, 500,000-square-foot vaccine and biologic medicine plant is off after they failed to meet an end-of-year timeline, though they said the door is open to renegotiate a new agreement. “I think there’s a [...]
The post Scorpius CEO acknowledges agreement with state to build Manhattan facility is no more appeared first on News Radio KMAN.









